Sort
39,280 grants matching “leukemia”
'Fat'Nucleosides and Nucleotides
$335,406University Of Maryland Balt Co Campus · R01 · FY2005 · AI
Mechanism-based targeting of unique survival signaling in residual tumors
$335,400Kris C. Wood · Duke University · R01 · FY2024 · CA
Regulation and function of IKKe in breast cancer initiation and maintenance
$335,392William C Hahn · Dana-Farber Cancer Inst · R01 · FY2011 · CA
The Function of Tribbles in the Pathogenesis of AML
$335,370Warren S Pear · University Of Pennsylvania · P01 · FY2007 · CA
Intervention Trials in Persons at Increased Genetic Risk of Cancer
$335,353Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
Gradient Biomaterials to Investigate Niche Regulation of Hematopoiesis
$335,305Brendan A. Harley · University Of Illinois At Urbana-Champaign · R01 · FY2016 · DK
Genomics of Acute Myelogenous Leukemia (AML): Relapse and Resistance Factors
$335,274John F Dipersio · Washington University · P01 · FY2012 · CA
Tyrosine Kinases and Lymphocyte Activation
$335,249Robert L Geahlen · Purdue University · R01 · FY2012 · AI
Turning off the molecular switch for pathological self-assembly of FUS
$335,244Nicolas Lux Fawzi · Brown University · R01 · FY2016 · GM
Signaling and Targeting of 6-Phosphogluconate Dehydrogenase in Human Cancers
$335,236Jing Chen · Emory University · R01 · FY2014 · CA
RNA Tumor Virus-Hematopoietic cell Interaction
$335,228Tufts University Boston · R01 · FY2005 · CA
RNA Tumor Virus-Hematopoietic cell Interaction
$335,228Tufts University Boston · R01 · FY2003 · CA
RNA Tumor Virus-Hematopoietic cell Interaction
$335,228Tufts University Boston · R01 · FY2004 · CA
Project 2: Targeting RTK Co-Dependencies in Triple-Negative Breast Cancer
$335,225Thomas Westbrook · Baylor College Of Medicine · P50 · FY2021 · CA
Project 3: Development of Strategies to Deplete Myelofibrosis Stem Cells
$335,170Ronald Hoffman · Icahn School Of Medicine At Mount Sinai · P01 · FY2022 · CA
MOLECULAR CHARACTERIZATION OF ACUTE MYELOID LEUKEMIA
$335,168Stanford University · R01 · FY2000 · CA
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells
$335,154Yong-Mi Kim · Children'S Hospital Of Los Angeles · R01 · FY2017 · CA
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells
$335,154Yong-Mi Kim · Children'S Hospital Of Los Angeles · R01 · FY2015 · CA
Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells
$335,154Yong-Mi Kim · Children'S Hospital Of Los Angeles · R01 · FY2016 · CA
The role of microRNAs in leukemic initiation and maintenance
$335,123Jun Lu · Yale University · R01 · FY2014 · CA
Targeting the p62 signalosome in leukemia.
$335,119Jing Fang · University Of South Carolina At Columbia · R01 · FY2017 · CA
Targeting the p62 signalosome in leukemia.
$335,119Jing Fang · University Of South Carolina At Columbia · R01 · FY2020 · CA
Targeting the p62 signalosome in leukemia.
$335,119Jing Fang · University Of South Carolina At Columbia · R01 · FY2018 · CA
Targeting the p62 signalosome in leukemia.
$335,119Jing Fang · University Of South Carolina At Columbia · R01 · FY2021 · CA
Identifying and targeting evolutionary trajectories in cancer
$335,090Michael Hemann · Massachusetts Institute Of Technology · R01 · FY2022 · CA